|Articles|December 1, 2012

Atypical antipsychotics may raise LUTS risk in women

Women taking atypical antipsychotic medications (AAPs) have about a 3-fiold higher prevalence of lower urinary tract symptoms (LUTS) compared with nonusers, a study on the presence of LUTS among users of psychoactive medications has found.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Subscribe

Related Content

Endometriosis as a systemic disease, with Hugh Taylor, MD

ByHugh Taylor, MD

September 14th 2026

FDA accepts extended duration sNDA for copper intrauterine system | Image credit: Contemporary OB/GYN

FDA accepts extended duration sNDA for MIUDELLA IUD

ByJoshua Fitch, Senior Editor

September 14th 2026

Certolizumab pegol's FDA breakthrough designation, atogepant's LUNA results, deep implant removal guidance

ByJoshua Fitch, Senior Editor

September 14th 2026

Amber Watters, MD, on emergency preparedness and building a version program

ByAmber Watters, MD, MS

September 11th 2026

New tool translates pregnancy test research into individualized patient counseling resource

ByAlexandra C. Sundermann, MD, PhD

September 11th 2026

Latest CME

In-Person + Virtual Event

Join Us at The Pathology Meeting in Las Vegas

October 5, 2026

In-Person + Virtual Event

Join Us at The Pathology Meeting in Las Vegas

October 4-5, 2026

Case-based Simulation

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Rachel N. Grisham, MD

Atypical antipsychotics may raise LUTS risk in women

Related Content

Endometriosis as a systemic disease, with Hugh Taylor, MD

FDA accepts extended duration sNDA for MIUDELLA IUD

Certolizumab pegol's FDA breakthrough designation, atogepant's LUNA results, deep implant removal guidance

Amber Watters, MD, on emergency preparedness and building a version program

New tool translates pregnancy test research into individualized patient counseling resource

Latest CME

Join Us at The Pathology Meeting in Las Vegas

Join Us at The Pathology Meeting in Las Vegas

SimulatEd™: A Roadmap to Personalized Care Plans and Shared Decision-Making in Low-Grade Serous Ovarian Cancer

Trending on Contemporary OB/GYN

Endometriosis as a systemic disease, with Hugh Taylor, MD

FDA accepts extended duration sNDA for MIUDELLA IUD

Society of Family Planning issues first guidance on deep and nonpalpable contraceptive implant removal

Certolizumab pegol's FDA breakthrough designation, atogepant's LUNA results, deep implant removal guidance

Amber Watters, MD, on emergency preparedness and building a version program